Kidney platforms could reduce animal testing in tox studies
Kidney disease researchers at the University of Washington will use a multimillion-dollar federal grant to advance drug development platforms that would reduce reliance on animal tests. The investigators, in the UW schools of Medicine and Pharmacy, received the $7.3 million award from the National Center for… Read More